NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ENPICOM

ENPICOM

Private
's-HertogenboschHealthcare & Life Scienceshttps://enpicom.com/

Last Round

VC Round

Mar 21, 2024

Total Funding Raised

$1.36M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ENPICOM is a bioinformatics software company that provides a cloud-based platform to manage, analyze, and visualize immunogenomics data for antibody and vaccine discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

immune repertoire sequencingbioinformatics softwarebioinformatics platformimmunomicsimmune repertoireantibody discoveryBCR sequencingTCR sequencingB-cell receptor analysisT-cell receptor analysisvaccine developmentclonotype trackingbioinformatics servicesvertical SaaSdevelopability predictionbiotech R&D tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ENPICOM Comparables

Compare ENPICOM with similar companies based on industry and business-model similarity.

ENPICOM comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MiLaboratories
88%
iRepertoire, Inc.
85%
NaturalAntibody
84%

ENPICOM Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 21, 2024
Series B ExtensionJun 28, 2023
Series BJan 13, 2022
Series AMar 5, 2019

Key People

Founding team and executive leadership

Nicola Bonzanni

Founder and Chief Executive Officer

Founding Team

Jorrit Posthuma

Chief Technology Officer

Executive Team

Pablo Mendes de León

CFO

Executive Team

ENPICOM Investors

Notable investors and investment history

ENPICOM investors
InvestorRounds
Nextgen VenturesSeries A, Series B Extension, Series B
Arches CapitalSeries A, Series B Extension, Series B
BOM Brabant VenturesVC Round, Series A, Series B Extension, Series B
BOP Impact VenturesVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Joined the Pistoia Alliance to lower barriers in life science R&D.

  • Nov 4, 2025

    Launched interview series 'Models & Molecules' about biology and computational science.

ENPICOM Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ENPICOM Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ENPICOM's valuation, stock price, and market status.

Firmographic Details

Headquarters's-Hertogenbosch
Employee Range24
Year Founded2015
Last FundingMar 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.